Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS

NCT03918304 · clinicaltrials.gov ↗

COMPLETED

Status

923

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Sponsor

AstraZeneca